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Abstract
IMPORTANCE Frailty is a common geriatric syndrome of significant public health importance, yet
there is limited understanding of the risk of frailty development at a population level.
OBJECTIVE To estimate the global incidence of frailty and prefrailty among community-dwelling
adults 60 years or older.
DATA SOURCES MEDLINE, Embase, PsycINFO,Web of Science, CINAHL Plus, and AMED (Allied and
Complementary Medicine Database) were searched from inception to January 2019 without
language restrictions using combinations of the keywords frailty, older adults, and incidence. The
reference lists of eligible studies were hand searched.
STUDY SELECTION In the systematic review, 2 authors undertook the search, article screening, and
study selection. Cohort studies that reported or had sufficient data to compute incidence of frailty
or prefrailty among community-dwelling adults 60 years or older at baseline were eligible.
DATA EXTRACTIONAND SYNTHESIS Themethodological quality of included studies was assessed
using The Joanna Briggs Institute’s Critical Appraisal Checklist for Prevalence and Incidence Studies.
Meta-analysis was conducted using a random-effects (DerSimonian and Laird) model.
MAINOUTCOMES ANDMEASURES Incidence of frailty (defined as new cases of frailty among
robust or prefrail individuals) and incidence of prefrailty (defined as new cases of prefrailty among
robust individuals), both over a specified duration.
RESULTS Of 15 176 retrieved references, 46 observational studies involving 120805 nonfrail (robust
or prefrail) participants from 28 countries were included in this systematic review. Among the
nonfrail individuals who survived amedian follow-up of 3.0 (range, 1.0-11.7) years, 13.6% (13 678 of
100 313) became frail, with the pooled incidence rate being 43.4 (95% CI, 37.3-50.4; I2 = 98.5%)
cases per 1000 person-years. The incidence of frailty was significantly higher in prefrail individuals
than robust individuals (pooled incidence rates, 62.7 [95% CI, 49.2-79.8; I2 = 97.8%] vs 12.0 [95% CI,
8.2-17.5; I2 = 94.9%] cases per 1000 person-years, respectively; P for difference < .001). Among
robust individuals in 21 studies who survived amedian follow-up of 2.5 (range, 1.0-10.0) years, 30.9%
(9974 of 32 268) became prefrail, with the pooled incidence rate being 150.6 (95% CI, 123.3-184.1;
I2 = 98.9%) cases per 1000 person-years. The frailty and prefrailty incidence rates were significantly
higher in women than men (frailty: 44.8 [95% CI, 36.7-61.3; I2 = 97.9%] vs 24.3 [95% CI, 19.6-30.1;
I2 = 8.94%] cases per 1000 person-years; prefrailty: 173.2 [95% CI, 87.9-341.2; I2 = 99.1%] vs 129.0
(continued)
Key Points
Question What is the incidence of
frailty and prefrailty among community-
dwelling adults 60 years or older?
Findings In this systematic review and
meta-analysis involving data frommore
than 120000 older adults from 28
countries, the incidence of frailty and
prefrailty was estimated as 43.4 and
150.6 new cases per 1000 person-years,
respectively. The frailty and prefrailty
incidence rates varied by sex, diagnostic
criteria, and country income level.
Meaning Results of this study suggest
that the risk of developing frailty and
prefrailty is high among community-
living older adults; as such, appropriate
interventions are needed.
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Abstract (continued)
[95% CI, 73.8-225.0; I2 = 98.5%] cases per 1000 person-years). The incidence rates varied by
diagnostic criteria and country income level. The frailty and prefrailty incidence rates were
significantly reduced when accounting for the risk of death.
CONCLUSIONS ANDRELEVANCE Results of this study suggest that community-dwelling older
adults are prone to developing frailty. Increased awareness of the factors that confer high risk of
frailty in this population subgroup is vital to inform the design of interventions to prevent frailty and
tominimize its consequences.
JAMA Network Open. 2019;2(8):e198398. doi:10.1001/jamanetworkopen.2019.8398
Introduction
The increasing average life expectancy has contributed to aging of the world’s population.1 By 2050,
approximately 21.3%of the global populationwill be 60 years or older,2 up from9.2% in 1990. Frailty,
a clinical syndrome characterized bymarked vulnerability due to decline in reserve and function
across multiple physiologic systems, is common among older people.3,4 Frailty manifests as the
inability to tolerate stressful events and has been associated with adverse outcomes, such as falls,5
delirium,6 institutionalization,7 incident disability,8 andmortality.9 Frailty is also an independent risk
factor for poor outcomes after surgery (eg, prolonged hospitalizations, increased susceptibility to
deconditioning, and faster functional decline)10 and is associated with higher health care use11 and
corresponding costs.12 There is a growing interest among stakeholders in aged care to better
understand the patterns and determinants of frailty.13
Frailty is difficult to diagnose, particularly within primary care settings, due to its coexistence
with other age-related conditions and as a result of the lack of a universally accepted clinical
definition.14,15 There is also debate about frailty screening, especially in relation to screening
eligibility, as well as where and when it should be done.16
Frailty phenotype and deficit accumulation are 2main approaches to frailty assessment.4 Using
the phenotype approach, Fried et al17 defined frailty as a predominantly physical condition requiring
the presence of 3 or more of the following 5 components: weight loss, exhaustion, weakness,
slowness, and low physical activity. However, Rockwood et al18 characterized frailty as an
accumulation of deficits (symptoms, signs, functional impairment, and laboratory abnormalities) and
stipulated that more deficits confer greater risk. These 2 frailty conceptualizations have been
extensively validated and are widely used. Beyond these conceptualizations of frailty, several other
definitions are present in the literature.19 Many definitions consider frailty to be a dynamic process
with an identifiable intermediate stage, usually referred to as prefrailty.20
Since 2000, frailty-related research has increased exponentially.15 Nonetheless, the
epidemiological evidence on frailty is dominated by a focus on prevalence. Incidence remains poorly
understood. AlthoughGalluzzo et al21 previously performed a systematic review on frailty incidence,
their analysis focused on European ADVANTAGE Joint Action countries and included 6 studies, with
no meta-analysis performed. With a growing worldwide interest in healthy aging,22 improved
understanding of the incidence of frailty may help deepen the discourse around themaintenance of
functional ability in old age. Therefore, we conducted a systematic review and meta-analysis to
summarize the available global epidemiological data on the incidence of frailty and prefrailty among
community-dwelling adults 60 years or older.
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Methods
This systematic review andmeta-analysis followed the Preferred Reporting Items for Systematic
Reviews andMeta-analyses23 (PRISMA) andMeta-analysis of Observational Studies in Epidemiology24
(MOOSE) reporting guidelines. The study protocol is registered at PROSPERO (CRD42019121302).25
Study Eligibility Criteria
Two of us (R.O-A. and K.L.C) independently determined study eligibility, and any disagreements were
resolved via consensus involving a third reviewer (D. Liew). The inclusion criteria were cohort studies
that reported or had sufficient data to compute incidence of frailty or prefrailty among community-
dwelling adults 60 years or older at baseline. Frailty status was considered categorically as robust,
prefrail, or frail.26 Frailty could have been diagnosed by any method, but studies needed to specify
their definition. For the Fried phenotype, individuals are often classified as robust, prefrail, or frail if 0,
1 to 2, or 3 or more of the criteria (ie, weight loss, exhaustion, weakness, slowness, and low physical
activity) are met, respectively.17 For the deficit accumulation approach, the definitions of robust,
prefrail, and frail were as specified by study authors, as has been done previously.27,28 Incidence of
frailty was defined as new cases of frailty among robust or prefrail individuals, and incidence of
prefrailty was defined as new cases of prefrailty among robust individuals, both over a specified
duration.Whenmultiple studies used the same cohort, the studywith themost complete data on the
largest number of participants was selected.
Exclusion criteria included studies focusing on institutionalized or hospitalized adults, residents
of nursing homes (because these populations are often predominantly frail),29 or populations
selected on the basis of an index disease. Studies reporting themean frailty scores but without data
on incidence were excluded, as were randomized clinical trials. Studies of individuals across the life
span were excluded unless data were specifically available for those 60 years or older at baseline.
Search and Selection of Studies
In the systematic review, 2 of us (R.O-A. and K.L.C.) undertook the search, article screening, and
study selection. MEDLINE, Embase, PsycINFO,Web of Science, CINAHL Plus, and AMED (Allied and
Complementary Medicine Database) were searched from inception to January 2019 without
language restrictions using combinations of the keywords frailty, older adults, and incidence. eTable 1
in the Supplement lists the search terms and strategy for MEDLINE (via Ovid), which were adapted
for other databases. The reference lists of eligible studies were hand searched. Conference abstracts,
editorials, andmeeting reports were excluded.
StudyQuality Assessment andData Extraction
Two of us (R.O-A. and K.L.C.) evaluated each included study for methodological quality using The
Joanna Briggs Institute’s Critical Appraisal Checklist for Prevalence and Incidence Studies.30 This
checklist consists of 9 criteria, and studies were ineligible if fewer than 5 of the criteria were achieved.
The following information was collected from individual articles: study details (authors, year of
publication, country, and study name), participant characteristics (sample size and percentage of
women), frailty measurement method, duration of follow-up, and incidence data. Sex-stratified or
age-stratified incidence data were collected, where available. Authors were contacted for additional
data or clarification, when required.
Statistical Analysis
For each study, we recorded or calculated incidence rates of frailty or prefrailty per 1000 person-
years based on the event rates and themean duration of follow-up.27,31-33 Exact methods according
to the Poisson distribution were adopted to calculate 95% CIs for incidence rates.34 There were 2
kinds of studies, including (1) those that used a 100% survivor cohort (ie, assessed frailty status at 2
time points, excluding persons who died in-between) and (2) those that accounted for people in the
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cohort who died without developing frailty. Therefore, to improve the comparability of these 2 types
of studies, as well as to minimize the consequences of survivorship bias,35 we recalculated the
incidence rate in the latter studies (ie, studies that reported transition to deaths) by restricting the
sample to the surviving cohort with frailty data.27,36
A random-effects (DerSimonian and Laird) meta-analysis was conducted using the
log-transformed incidence rates and corresponding 95% CIs. The random-effects model was
selected a priori due to the anticipated heterogeneity of the included studies. Statistical evidence of
between-study heterogeneity was examined using the CochranQ test and the I2 statistic.37 I2 values
of 25%, 50%, and 75%were considered to be low, moderate, and high degrees of heterogeneity,
respectively.37 The robustness of pooled estimates were assessed via leave-1-out sensitivity analyses.
A studywas considered to be influential if the pooled estimatewithout it was notwithin the 95%CIs
of the overall pooled estimate. Sex-specific incidence data were pooled, as were the incidence rates
by assessment method. To examine the extent to which the pooled incidence rates were explained
by these factors, we also performed random-effects meta-regression using the following variables:
measurement method (physical phenotype vs other), country income level (lower-income and
middle-income country [LMIC] vs high-income country [HIC]), study region (North America, Europe,
Asia, or other), person-years of follow-up (per unit increase), whether the study enrolled only elderly
people 70 years or older (no vs yes), study population (mix, female only, or male only), and
publication years (2009 or earlier, 2010 to 2014, or 2015 to 2019). The HICs were defined as any
country with a gross national income per capita in 2017 of US $12 056 or more.38 Differences
between subgroups were compared via a χ2 test. Publication bias was assessed via visual inspection
of funnel plots, and statistical assessment was evaluated using the Egger test.39
To provide context of the burden of frailty, data on the proportion of older adults who were
nonfrail were pooled using the respective study baseline data, if reported. Themeta-analysis was
performed using the Freeman-Tukey double arcsine transformed proportions to stabilize the
variance.40
All analyses were performed using statistical software (Stata, version 15.0/IC; StataCorp LP).
Two-tailed P < .05 was considered statistically significant.
Results
Selection Process
Of 15 176 retrieved citations, 142 articles were selected for full-text assessment (Figure 1). After full-
text evaluation, 42 studies met the eligibility criteria. Four additional studies were retrieved by
reference screening, resulting in a total of 46 studies (involving 48 cohorts) included in the
systematic review. No study was excluded on the basis of The Joanna Briggs Institute
methodological review.30
Study Characteristics
The characteristics of the 46 included studies are summarized in Table 1. The studies involved
120805 nonfrail (robust or prefrail) older adults from 28 countries. Nine studies were from Asia, 14
from North America, 2 from South America, 15 from Europe, and 4 from Australia, and 2 were cross-
regional studies. eFigure 1 in the Supplement shows the geographical spread of the countries where
data were collected. The median sample size across studies was 1054 (range, 44-28 181), and the
median follow-up was 3.0 (range, 1.0-11.7) years. In 30 studies involving 101 259 participants, 73.3%
were women. Frailty was assessed using the original or modified versions of the Fried criteria in 39
studies, 4 studies used the Frailty Index, and 1 study used both the Frailty Index and the Fried criteria,
whereas 2 studies used other criteria. Among the studies using the deficit accumulation approach,
the number of deficits used ranged from 20 to 44.
In 31 studies, data on baseline proportion of older adults without frailty were available. In these
studies, involving 118 411 individuals at baseline, the pooled proportion without frailty was 82.8%
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(95% CI, 75.8%-88.8%; I2 = 99.8%). The pooled proportion that was nonfrail was 86.5% (95% CI,
78.9%-92.7%; I2 = 99.8%) across studies that used the Fried criteria and 58.9% (95% CI,
44.2%-72.8%; I2 = 99.6%) across studies that used other criteria (P for difference < .001).
Incidence of Frailty
To estimate the global incidence of frailty, data were included from 46 studies.41-81,83-86 Among
people without frailty at baseline who survived amedian follow-up of 3.0 (range, 1.0-11.7) years,
13.6% (13 678 of 100 313) became frail. The pooled incidence rate of frailty was 43.4 (95% CI, 37.3-
50.4; I2 = 98.5%) cases per 1000 person-years (Figure 2). There was no evidence of publication bias
as determined by funnel plot visualization (eFigure 2 in the Supplement) or via the Egger test
(P = .48). A leave-1-out sensitivity analysis did not show a dominance of any single study (eTable 2 in
the Supplement).
The pooled frailty incidence rate was 40.0 (95% CI, 34.5-48.5; I2 = 98.2%) cases per 1000
person-years when using the Fried phenotype. The pooled frailty incidence rate was 71.3 (95% CI,
56.9-89.3; I2 = 94.0%) cases per 1000 person-years when using other criteria (P for
difference = .003).
Among 20 studies that reported transitions to death, the proportion of nonfrail people who
died over a median follow-up of 4.5 years was 12.9% (5989 of 46 358). When factoring in the risk of
death, the pooled incidence rate of frailty was 35.9 (95% CI, 28.0-46.1; I2 = 98.7%) cases per 1000
person-years (eFigure 3 in the Supplement). Restricting the analyses to those who survived in these
19 studies resulted in a pooled frailty incidence rate of 44.1 (95%CI, 34.0-57.2; I2 = 98.8%) cases per
1000 person-years (eFigure 4 in the Supplement).
Twenty studies reported the incidence of frailty among 19 613 people who were prefrail and
17 523 people who were robust at baseline and who survived over a median follow-up of 3.0 years.
During the follow-up, 4.6% (807 of 17 523) of individuals who were robust and 18.5% (3628 of
19 613) of individuals who were prefrail developed frailty. The pooled frailty incidence rates among
the robust and prefrail individuals were 12.0 (95% CI, 8.2-17.5; I2 = 94.9%) and 62.7 (95% CI,
49.2-79.8; I2 = 97.8%) cases per 1000 person-years, respectively, with the difference being
statistically significant (P value for difference < .001).
Figure 1. PRISMADiagram of the Study Selection Process
4395 Duplicates removed
10 639 Records removed after title
and abstract screening
10 781 Records after duplicate removal
142 Records assessed for full text
46 Studies included in the meta-analysis
4 Studies identified via reference screening
15 176 Total search hits
2677 MEDLINE
63 AMED
4060 Embase
1848 CINAHL
5651 Web of Science
877 PsychINFO
100 Records removed after full-text assessment
9 Mix of ages
6 Specific disease population
19 Conference abstracts
13 No relevant incidence data
5 Hospitalized or institutionalized cohort
1 Randomized clinical  trial
47 Publication from same cohort AMED indicates Allied and Complementary Medicine
Database; PRISMA, Preferred Reporting Items for
Systematic Reviews andMeta-analyses.
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Table 1. Descriptive Characteristics of 46 Studies Included in the Systematic Review
Source (Study Region) Study or Cohort Name
Sample Sizea
Age
Range, y % Female
Mean
Follow-up, y Frail Diagnostic CriteriaAll Robust Prefrail
Ahmad et al,41 2018 (Malaysia) NA 1677 605 1072 ≥60 61.6 1.0 Fried criteria
Alencar et al,42 2015 (Brazil) NA 151 43 108 ≥65 NS 1.0 Fried criteria
Ayers et al,43 2017
(United States)
A: LonGenity study
B: Central Control of Mobility in Aging
A: 549
B: 256
NS NS ≥65 NS A: 3.18
B: 1.74
Fried criteria
Baulderstone et al,44 2012
(Australia)
Australian Longitudinal Study of Aging 1298 NS NS ≥65 49.0 8.0 Fried criteria
Bentur et al,45 2016 (Israel) Members of Maccabi Healthcare Services 161 NS NS ≥65 NS 6.0 Vulnerable Elders
Survey-13
Borrat-Besson et al,46 2013
(Sweden, Denmark, Germany,
the Netherlands, Belgium,
France, Switzerland, Austria,
Spain, Italy, Poland, Czech
Republic)
SHARE survey 9416 5307 4109 ≥60 50.5 4.3 Fried criteria
Castrejón-Pérez et al,47 2017
(Mexico)
Prospective Mexican Study of Nutritional
and Psychosocial Markers of Frailty
237 NS NS 70-95 51.5 3.0 Fried criteria
Chhetri et al,48 2017 (China) Beijing Longitudinal Study of Aging II 4378 NS NS ≥65 NS 1.0 Frailty Index (32 deficits
used: on a scale of 0-1,
frailty defined as ≥0.25
deficits)
Dalrymple et al,49 2013
(United States)
Cardiovascular Health Study 3459 NS NS ≥65 100 3.0 Fried criteria
Doba et al,50 2012 (Japan) Health Research Volunteer Study 373 NS NS >70 54.8 5.0 Canadian Study for Health
and Aging–Clinical Frailty
Scale
Doi et al,51 2018 (Japan) Obu Study of Health Promotion for the
Elderly
4322 1978 2344 ≥65 51.9 4.0 Fried criteria
Ensrud et al,52 2010
(United States)
Study of Osteoporotic Fractures 4551 NS NS ≥65 100 4.5 Fried criteria
Espinoza et al,53 2012
(United States)
San Antonio Longitudinal Study of Aging 507 209 298 ≥65 NS 6.4 Fried criteria
Gale et al,54 2013
(United Kingdom)
English Longitudinal Study of Ageing 2146 NS NS ≥60 54.0 4.0 Fried criteria
García-Esquinas et al,55 2015
(Spain)
Toledo Study for Healthy Aging 1289 NS NS ≥65 58.4 3.5 Fried criteria
García-Esquinas et al,56 2016
(France)
Integrated multidisciplinary approach
cohort
473 NS NS ≥65 37.8 2.0 Fried criteria
Gill et al,57 2006 (United
States)
Precipitating Events Project 536 167 369 ≥70 NS 1.5b Fried criteria
Gnjidic et al,58 2012 (Australia) Concord Health and Aging in Men Project 1242 NS NS ≥70 0 2.0 Fried criteria
Gomes et al,59 2018 (Colombia,
Albania, Brazil, Canada)
International Mobility in Aging Study 1620 816 804 65-74 NS 2.0 Fried criteria
Gruenewald et al,60 2009
(United States)
MacArthur Study of Successful Aging 803 440 363 70-79 55.5 3.0 Fried criteria
Hyde et al,61 2016 (Australia) Kimberley Healthy Adults Project in
Indigenous Australians
44 NS NS ≥60 NS 7.0 Frailty Index (20 deficits
used: on a scale of 0-1,
frailty defined as ≥0.2
deficits)
Iwasaki et al,62 2018 (Japan) Niigata Study 322 NS NS 75 43.8 4.2 Fried criteria
Kalyani et al,63 2012
(United States)
Women’s Health and Aging Study II 329 NS NS 70-79 100 8.6 Fried criteria
Kim et al,64 2017 (Japan) Otasha-Kenshin study 684 NS NS ≥75 100 4.0 Fried criteria
Lanziotti Azevedo da Silva
et al,65 2015 (Brazil)
NA 173 63 110 ≥65 NS 1.1 Fried criteria
Lee et al,66 2014 (Hong Kong) Mr and Mrs OS 2893 1336 1557 ≥65 48.1 2.0 Fried criteria
Liu et al,67 2018 (China) Chinese Longitudinal Healthy Longevity
Survey
7601 2252 5349 65-99 NS 3.0 Frailty Index (44 deficits
were used: on a scale of
0-1, robust, prefrail, and
frail were defined as <0.1,
0.1-0.21, and >0.21,
respectively)
Lorenzo-López et al,68 2019
(Spain)
VERISAÚDE study 519 140 379 ≥65 NS 1.0 Fried criteria
Ottenbacher et al,69 2009
(United States)
Hispanic Established Populations
Epidemiologic Studies of the Elderly
1525 737 788 ≥65 42.0 10.0 Fried criteria
Pilleron et al,70 2017 (France) Three-City Bordeaux Study 1265 NS NS ≥65 65.4 11.7 Fried criteria
(continued)
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Ten studies directly compared frailty incidence between 11 959men and 13 870womenwho
survived amedian follow-up of 4.0 years. Among themen and women, 9.2% (1099 of 11 959) and
15.6% (2164 of 13 870), respectively, developed frailty. The pooled incidence rates of frailty in men
and women in these studies were 24.3 (95% CI, 19.6-30.1; I2 = 89.4%) and 44.8 (95% CI, 36.7-61.3;
I2 = 97.9%) cases per 1000 person-years, respectively, with the difference being statistically
significant (P value for difference = .01).
Only 2 studies48,75 reported age-stratified frailty incidence rate, with inconsistent age groups
being used. Therefore, data were not pooled, although both studies reported consistent increases in
frailty incidence with increasing age.
Incidence of Prefrailty
Twenty-one studies41,42,46,51,53,57,59,60,65-69,71,72,77,79-83 reported data on the global incidence of
prefrailty among 32 268 community-dwelling older adults who were robust at baseline and survived
a median follow-up of 2.5 (range, 1.0-10.0) years. During the follow-up, 30.9% (9974 of 32 268)
became prefrail. The pooled incidence rate of prefrailty was 150.6 (95% CI, 123.3-184.1; I2 = 98.9%)
Table 1. Descriptive Characteristics of 46 Studies Included in the Systematic Review (continued)
Source (Study Region) Study or Cohort Name
Sample Sizea
Age
Range, y % Female
Mean
Follow-up, y Frail Diagnostic CriteriaAll Robust Prefrail
Pollack et al,71 2017
(United States)
Osteoporotic Fractures in Men Study 4664 2322 2342 ≥65 0 4.6 Fried criteria
Potier et al,72 2018 (Belgium) NA 72 28 44 ≥70 NS 1.33 Fried criteria
Ramsay et al,73 2018
(United Kingdom)
British Regional Heart Study 1054 NS NS 71-92 0 3.0 Fried criteria
Sandoval-Insausti et al,74 2016
(Spain)
Seniors-ENRICA 1822 NS NS ≥60 51.3 3.5 Fried criteria
Saum et al,75 2017 (Germany) ESTHER cohort 1446 NS NS ≥65 NS 3.0 Fried criteria
Semba et al,76 2006
(United States)
Women’s Health and Aging Study I 463 NS NS ≥65 100 3.0 Fried criteria
Serra-Prat et al,77 2017 (Spain) NA 252 91 161 ≥75 NS 1.0b Fried criteria
Shah et al,78 2018
(United States)
Health and Retirement Study 6073 NS NS ≥65 56.0 4.0c Fried criteria
Stephan et al,79 2017
(Germany)
KORA-Age cohort study 740 218 522 ≥65 NS 3.0 Frailty Index (30 items
used: on a scale of 0-1
robust, prefrail, and frailty
were defined as <0.08,
0.08 to <0.25, and ≥0.25,
respectively)
Swiecicka et al,80 2018 (Italy,
Belgium, Poland,
United Kingdom, Spain,
Hungary, Estonia)
European Male Ageing Study 806 550 256 ≥60 0 4.3 Fried criteria
Thompson et al,81 2018
(Australia)
North West Adelaide Health Study Fried
criteria:
590
Frailty
Index: 394
Fried
criteria:
233
Frailty
Index:
175
Fried
criteria:
357
Frailty
Index:
219
≥65 48.1 4.5 Fried criteria and Frailty
Index (30 items used: on a
scale of 0-1, robust,
prefrail, and frailty were
defined as <0.08, 0.08 to
<0.25, and ≥0.25,
respectively)
Tom et al,82 2017 (Belgium,
Canada, France, Germany, Italy,
the Netherlands, Spain,
United Kingdom,
United States)
Global Longitudinal Study of
Osteoporosis in Women
14 752 14 752 Excluded ≥60 100 2.0 Fried criteria
Trevisan et al,83 2016 (Italy) Progetto Veneto Anziani 2702 1261 1441 ≥65 58.7 4.4 Fried criteria
Wang et al,84 2019 (Taiwan) NA 541 NS NS 65-99 NS 1.0 Fried criteria
Woods et al,85 2005
(United States)
Women’s Health Initiative Observational
Study
28 181 NS NS 65-79 100 3.0 Fried criteria
Zaslavsky et al,86 2016
(United States)
Adult Changes in Thought Study 1848 NS NS ≥65 57.9 4.8 Fried criteria
Abbreviations: NA, not applicable; NS, not specified.
a Where available, sample size includes those who died but excludes people lost to
follow-up. The total number of nonfrail people across all studies was 120805.
b Data were extracted from the follow-up duration with themost comprehensive data.
c We selected the periods with themost comprehensive data as derived from a survival
analysis.
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cases per 1000 person-years (Figure 3). There was no evidence of publication bias as determined by
visual inspection of funnel plots (eFigure 5 in the Supplement) or bymeans of the Egger test. A
leave-1-out sensitivity analysis did not alter the results (eTable 3 in the Supplement).
The pooled incidence rate of prefrailty was 150.9 (95% CI, 120.2-182.6; I2 = 98.8%) cases per
1000 person-years when using the Fried phenotype. The pooled incidence rate of prefrailty was
140.4 (95% CI, 97.2-202.9; I2 = 93.4%) cases per 1000 person-years when using other criteria (P for
difference = .52).
Figure 2. Forest Plot of the Incidence Rates (per 1000 Person-Years) of Frailty Among Community-Dwelling Older Adults
Weight,
%
1 100010010
Incidence Rate per 1000 Person-Years (95% CI)
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2.22Ayers et al,43 2017 (cohort A)
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2.26Baulderstone et al,442012
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30/147
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98/1745.8
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63/666
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35/711
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214/9423
65/1755
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55/2457
230/8584
162/4511.5
73/946
99/766.5
77/2484
88/3240
48/2409
18/182
48/1352.4
77/1737.2
139/2736
16/190.3
172/5660
1335/17 739
30/519
158/7630
299/11 372
470/19 582.2
7/95.8
107/3162
132/6377
152/4338
205/1389
22/249
878/24 292
117/2079
42/3465.8
134/2263.5
377/9002.4
23/541
4158/84 543
578/8870.4
Bentur et al,45 2016
2.30
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2.30
2.27
2.18
2.29
2.30
2.15
2.27
2.26
2.19
2.22
2.20
2.21
2.13
1.86
2.13
2.20
2.25
2.26
2.31
2.02
2.26
2.28
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2.23
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2.25
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2.30
2.31
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2.24
2.25
2.29
2.10
1.93
1.95
1.38
1.81
Borrat-Besson et al,46 2013
Castrejón-Pérez et al,47 2017
Chhetri et al,48 2017
Dalrymple et al,49 2013
Doba et al,50 2012
Doi et al,51 2018
Ensrud et al,52 2010
Espinoza et al,53 2012
Gale et al,54 2013
García-Esquinas et al,55 2015
García-Esquinas et al,56 2016
Gill et al,57 2006
Gnjidic et al,58 2012
Gomes et al,59 2018
Gruenewald et al,60 2009
Hyde et al,61 2016
Iwasaki et al,62 2018
Kalyani et al,63 2012
Kim et al,64 2017
Lanziotti Azevedo de Silva et al,65 2015
Lee et al,66 2014
Liu et al,67 2018
Lorenzo-López et al,68 2019
Ottenbacher et al,69 2009
Pilleron et al,70 2017
Pollack et al,71 2017
Potier et al,72 2018
Ramsay et al,73 2018
Sandoval-Insausti al,74 2016
Saum et al,75 2017
Semba et al,76 2006
Serra-Prat et al,77 2017
Shah et al,78 2018
Stephan et al,79 2017
Swiecicka et al,80 2018
Thompson et al,81 2018
Trevisan et al,83 2016
Wang et al,84 2019
Woods et al,85 2005
Zaslavsky et al,86 2016
Overall effect: P < .001; I2 = 98.5% 
Incidence Rate per 1000
Person-Years (95% CI)
204.08 (137.69-291.34)
42.34 (33.07-53.40)
56.13 (45.57-68.41)
85.31 (60.37-117.09)
17.53 (15.07-20.27)
94.59 (72.69-121.03)
20.90 (19.48-22.39)
49.23 (34.29-68.46)
106.67 (97.21-116.80)
22.71 (19.77-25.97)
37.04 (28.58-47.21)
19.99 (17.90-22.26)
40.35 (37.51-43.35)
22.39 (16.86-29.14)
26.79 (23.44-30.49)
35.91 (30.59-41.88)
77.17 (60.49-97.03)
129.16 (104.97-157.25)
31.00 (24.46-38.74)
27.16 (21.78-33.46)
19.93 (14.69-26.42)
98.90 (58.62-156.31)
35.49 (26.17-47.06)
44.32 (34.98-55.40)
50.80 (42.71-59.99)
84.08 (48.06-136.54)
30.39 (26.02-35.28)
75.26 (71.27-79.41)
57.80 (39.00-82.52)
20.71 (17.60-24.20)
26.29 (23.40-29.45)
24.00 (21.88-26.27)
73.10 (29.39-150.61)
33.84 (27.73-40.89)
20.70 (17.32-24.55)
35.04 (29.69-41.07)
147.59 (128.08-169.23)
88.35 (55.37-133.77)
36.14 (33.79-38.62)
56.28 (46.54-67.45)
12.12 (8.73-16.38)
59.20 (49.60-70.11)
41.88 (37.76-46.33)
42.51 (26.95-63.79)
49.18 (47.70-50.70)
65.16 (59.96-70.70)
43.36 (37.29-50.41)
Weights are from random-effects analysis. Forty-five studies were included.
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Among 13 studies that reported transitions to death, the proportion of robust people who died
over a median follow-up of 4.0 years was 7.8% (1253 of 16 134). When factoring in the risk of death,
the pooled incidence rate of prefrailty was 110.6 (95% CI, 84.8-144.2; I2 = 98.9%) cases per 1000
person-years (eFigure 6 in the Supplement). Restricting the analyses to those who survived in these
13 studies resulted in a pooled prefrailty incidence rate of 122.7 (95%CI, 95.7-157.5; I2 = 98.7%) cases
per 1000 person-years (eFigure 7 in the Supplement).
Four studies directly compared incidence of prefrailty among 4003men and 3655 womenwho
survived amedian follow-up of 4.2 years. In all, 32.6% (1305 of 4003) of the men and 40.1% (1465
of 3655) of the women became prefrail, at a pooled incidence rate of 129.0 (95% CI, 73.8-225.0;
I2 = 98.5%) and 173.2 (95% CI, 87.9-341.2; I2 = 99.1%) cases per 1000 person-years, respectively (P
for difference = .12). No study reported age-stratified prefrailty incidence data.
Meta-regression
In themultivariable random-effects meta-regression, measuring frailty as a physical phenotype was
associated with higher incidence than using other methods (adjusted odds ratio [aOR], 1.48; 95% CI,
1.02-2.15), although no statistically significant difference was observed for prefrailty incidence
(Table 2). Study region was not significantly associated with frailty and prefrailty incidence, but HICs
were associatedwith a lower incidence of frailty (aOR, 0.63; 95%CI, 0.42-0.95) and prefrailty (aOR,
0.30; 95% CI, 0.21-0.84) compared with LMICs. Studies published after 2009 were associated with
lower frailty incidence. The variables included in themultivariable models collectively explained
about 63.9% and 38.1% of the between-study variance for frailty and prefrailty incidence,
respectively.
Figure 3. Forest Plot of the Incidence Rates (per 1000 Person-Years) of Prefrailty Among Community-Dwelling Older Adults
Weight,
%
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Lee et al,66 2014
Liu et al,67 2018
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Pollack et al,71 2017
Potier et al,72 2018
Serra-Prat et al,77 2017
Stephan et al,79 2017
Swiecicka et al,80 2018
Thompson et al,81 2018
Tom et al,82 2017
Tom et al,82 2017b
Trevisan et al,83 2016
Overall effect: P < .001; I2 = 98.9% 
Incidence Rate per 1000
Person-Years (95% CI)
325.58 (178.00-546.27)
492.56 (438.22-551.78)
81.66 (77.94-85.51)
94.46 (87.73-101.57)
64.52 (50.29-81.51)
279.17 (216.35-354.53)
170.34 (150.91-191.59)
133.33 (114.36-154.55)
331.89 (210.39-498.00)
175.87 (160.25-192.61)
179.59 (168.82-190.88)
428.57 (327.05-551.66)
54.36 (47.66-61.74)
74.37 (69.16-79.88)
563.91 (349.07-862.00)
351.65 (240.53-496.42)
172.78 (142.40-207.73)
74.42 (63.83-86.26)
85.22 (67.47-106.21)
120.28 (114.76-125.99)
96.75 (91.79-101.92)
73.15 (65.55-81.40)
150.64 (123.26-184.08)
Weights are from random-effects analysis. Twenty-one studies were included.
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Table 2. Results of Univariable andMultivariable Random-EffectsMeta-regression of the Sources of Between-Study Heterogeneity
Variable
Univariable Multivariable
OR (95% CI) P Value
Adjusted
R2, % aOR (95% CI) P Value
Adjusted
R2, %
Incidence of Frailty
Measurement method
63.9
Physical phenotype 1 [Reference] NA
10.1
1 [Reference] NA
Other 1.78 (1.09-2.89) .02 1.48 (1.02-2.15) .03
Country income level
LMIC 1 [Reference] NA
7.6
1 [Reference] NA
HIC 0.59 (0.36-0.97) .04 0.63 (0.42-0.95) .03
Study region
North America 1 [Reference] NA
1.2
1 [Reference] NA
Europe 0.83 (0.52-1.32) .43 0.88 (0.63-1.24) .45
Asia 0.99 (0.59-1.67) .98 0.74 (0.50-1.10) .13
Other 1.45 (0.84-2.50) .18 1.23 (0.82-1.84) .31
Person-years of follow-up per unit increase 0.99 (0.99-1.00) .17 1.8 0.99 (0.99-0.99) .02
Enrolled only elderly people (≥70 y)
No 1 [Reference] NA
−2.1
1 [Reference] NA
Yes 1.08 (0.69-1.67) .34 1.18 (0.85-1.63) .31
Study population
Mix 1 [Reference] NA
5.8
1 [Reference] NA
Female only 1.13 (0.64-2.00) .67 1.14 (0.72-1.79) .57
Male only 0.52 (0.27-0.97) .04 0.55 (0.35-0.87) .01
Publication years
2009 Or earlier 1 [Reference] <.001
29.1
1 [Reference] NA
2010-2014 0.27 (0.14-0.54) <.001 0.24 (0.14-0.44) <.001
2015-2019 0.50 (0.27-0.95) .03 0.42 (0.22-0.77) .007
Incidence of Prefrailty
Measurement method
38.1
Physical phenotype 1 [Reference] NA
−1.7
1 [Reference] NA
Other 0.65 (0.23-1.79) .40 0.45 (0.18-1.16) NA
Country income level
LMIC 1 [Reference] NA
18.4
1 [Reference] NA
HIC 0.39 (0.17-0.90) .03 0.30 (0.21-0.84) .03
Study region
North America 1 [Reference] NA
−10.8
1 [Reference] NA
Europe 1.61 (0.63-4.10) .24 1.66 (0.62-4.49) .28
Asia 1.91 (0.63-5.82) .24 1.14 (0.33-3.90) .82
Other 1.22 (0.39-3.79) .72 0.56 (0.15-2.15) .36
Person-years of follow-up per unit increase 1.00 (0.99-1.00) .07 11.2 1.00 (0.99-1.00) .21
Enrolled only elderly people (≥70 y)
No 1 [Reference] NA
1.8
1 [Reference] NA
Yes 1.76 (0.64-4.81) .26 1.40 (0.44-4.47) .54
Study population
Mix 1 [Reference] NA
−0.1
1 [Reference] NA
Female only 1.47 (0.44-4.93) .51 1.02 (0.21-4.89) .98
Male only 0.69 (0.14-3.50) .64 0.49 (0.13-1.81) .25
Publication years
2009 Or earlier 1 [Reference] NA
2.8
1 [Reference] NA
2010-2014 0.33 (0.06-1.95) .21 0.49 (0.09-2.86) .39
2015-2019 0.56 (0.11-2.99) .48 0.76 (0.11-5.25) .76
Abbreviations: aOR, adjusted odds ratio; HIC, high-income country; LMIC, lower-income andmiddle-income country; NA, not applicable; OR, odds ratio.
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Discussion
We performed a systematic review andmeta-analysis to estimate the incidence of frailty and
prefrailty among community-dwelling older adults. Our results indicate the following: (1) frailty and
prefrailty incidence rates were approximately 43 and 151 new cases per 1000 person-years,
respectively; (2) the incidence of frailty and prefrailty was higher in women thanmen; and (3) the
incidence of frailty and prefrailty varied by frailty measurement method used and by country
income level.
Although not necessarily synonymous with aging, frailty is highly prevalent among older
people.3,4 Our pooled baseline data suggested that approximately 1 in 6 community-dwelling older
people may have frailty. Frailty has been associated with adverse health outcomes, such as falls,
disability, and death, as well as increased use of health care resources.8,9,12 Therefore, efforts to
reduce the burden of frailty could have substantial public health consequences.
Prevention of frailty requires a sound understanding of the risk factors. For example, it has been
demonstrated that individual chronic diseases (eg, cancers, type 2 diabetes,63,66,71 and
depression,77,85,87 or their co-occurrence [ie, multimorbidity]) have been shown to increase the risk
of frailty.88,89 With an estimated 66% of older people having at least 2 chronic medical conditions,90
effective preventive strategies are paramount to reduce overall disease burden. The rising
prevalence of obesity among older adults91,92 needs greater attention because this condition,
particularly abdominal obesity, may increase the risk of frailty through the association with
proinflammatory processes, insulin resistance, fat infiltration of skeletal muscles, and hormonal
alterations.93,94 Many other sociodemographic, physical, biological, lifestyle (eg, smoking), and
psychological factors may equally contribute to the development of frailty and thus require tailored
solutions in different settings.95-98
We found a higher incidence of frailty and prefrailty in LMICs than HICs in our study, which is
consistent with prior observations of significantly higher prevalence of frailty and prefrailty in LMICs
compared with HICs.99 Some studies59,87,100 found that high income and educational levels and
greater access to and quality of health care confer lower frailty risk, whichmay partly explain the
disparity in frailty incidence between LMICs and HICs, presenting opportunity to prevent or delay the
onset of chronic pathologies associated with increased risk of frailty.88,101
Our meta-analysis suggests higher incidence of frailty and prefrailty in women thanmen.
Previous studies have shown consistently higher prevalence rates3,99 and frailty scores102 among
women thanmen across all age groups. The sex differences may be attributable to both biological
and socioeconomic factors. Nonetheless, women have been found to better tolerate frailty, as
evidenced by lower mortality rates at any frailty level or age, suggesting the existence of a male-
female health-survival paradox.102
To date, several interventions incorporating exercise, nutrition, cognitive training, geriatric
assessment, hormone therapy, andmanagement and prehabilitation have been evaluated for their
effectiveness at delaying or reversing frailty.103-107 Most of these interventions have demonstrated
feasibility, with adherence rates of about 70%.103 However, a recent systematic review reported
that, among the available primary care interventions to delay or reverse frailty, strength training and
protein supplementation ranked highest in terms of relative effectiveness and ease of
implementation.108 Conversely, mild-intensity mixed exercises, as well as educational or health
promotion activities, typically were in themidzone for both relative effectiveness and ease of
implementation, whereas comprehensive geriatric assessments and home visits were rankedmid to
low for both relative effectiveness and ease of implementation. In general, interventions targeting
behavioral change ranked low in relative effectiveness and at the midzone for ease of
implementation.108 However, it needs emphasizing that most interventions have been tested in
people who were frail or prefrail.103,108 Our meta-analysis showed that, among people who were
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robust, there were approximately 12 and 151 new cases of frailty and prefrailty per 1000 person-
years, respectively, suggesting that interventions aimed at preventing frailty and prefrailty in robust
populations could be important.
The lower pooled incidence when frailty was defined as a physical phenotype compared with
when a broad phenotype was used is consistent with prior meta-analyses that have demonstrated
higher frailty prevalence when using broad definitions vs the physical phenotype.3,99 Other studies3
have shown considerable variability in the literature regarding the use of the deficit accumulation
approach (as also observed in the present study), thus contributing to wide estimates of frailty
burden. Therefore, a harmonized definition of frailty may be useful.
Limitations and Future Directions
Our study had some limitations. There was substantial heterogeneity of the included studies.
Nonetheless, heterogeneity is often inevitable in meta-analyses of observational studies, and it does
not necessarily invalidate the findings.109We decided a priori to pool incidence data across studies
that met our inclusion criteria. Furthermore, potential sources of heterogeneity were investigated via
subgroup and random-effects meta-regression, which showed considerable heterogeneity in
incidence rates by frailty measurement method, country income level, and publication years of
studies. Meta-analysis of incidence data is also complicated by variable duration of follow-up. We
sought to overcome this by estimating person-years on the basis of themedian follow-up duration.
While this method is considered robust and is widely applied in the literature,27,31-33 a more precise
approach would have required the use of the actual data on person-years, which were unavailable in
more than 90%of studies.While frailty incidence varies by age, we could not perform age-stratified
analysis due to limited data, and we were unable to account for the influence of the mean age of
participants in the individual studies in the regressionmodels due to poor reporting. People who
develop frailty or prefrailty may regress27,36; however, the present analysis does not incorporate
regression rates. Finally, our abstract screeningmay havemissed relevant studies in which frailty was
not themain focus, but which contained information on the incidence of frailty (eg, frailty as a
covariate).
Overall, the study results reiterate the need for regular screening programs to assess older
people’s vulnerability to frailty development so that appropriate interventions can be implemented
in a timely manner.16 For example, frailty assessment could be considered as part of routine health
screening or could be instituted as a part of the core services delivered to older people within primary
health care and general practice settings.41 Because not all older people develop frailty, future studies
should examine protective factors against frailty so as to inform preventive strategies. Our data could
also inform health care planning and design of preventive strategies. However, the inequality in the
availability of frailty data according to geographical locations requires attention because it hampers
the opportunity to reliably forecast the future trajectory of the global burden of frailty, which is
needed to inform efficient planning and resource allocation, mindful of the growing aging
population.21
Conclusions
There is a high risk of frailty among community-dwelling older adults, and we observed that the
incidence of frailty varies by sex, region, country income level, and diagnostic criteria used. It is
imperative to improve understanding of the factors that confer increased risk of frailty. This will help
inform the design of interventions to prevent frailty orminimize its negative consequences on health.
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